GwangPyo began his career as a microbiologist, working in research for a number of years before finding a Kobiolabs. He has published more than 100 papers and patents on health and food environment such as microbiome. Since 2011, he has been a director of Center for Human and Environmental Microbiome(Seoul National University) and also a PI and board member of International Human Microbiome Consortium. Prior to joining Seoul National University as a professor of Environmental Health Microbiology, he conducted post-doctoral work from University of North Carolina Chapel Hill and served as a assistant professor at Dept. of Environmental Health from University of Texas Health Science Center afterwards. He earned a M.S. and Sc.D. in Environmental Health from Harvard University.
Chief Operating Officer
Cheolwon joined Kobiolabs as COO in Feb 2018. He has more than 20 years of extensive experiences from drug discovery & development to business development in a pharmaceutical industry. He most recently served as Head of Portfolio & BD at Alvogen Asia Pacific and Head of R&D at Alvogen Korea. Prior to that, he worked at LG Life Sciences and CJ Cheiljedang. Cheolwon has his B.A. in Pharmacy and his M.S. in Medicinal Chemistry from Seoul National University.
Chief Technology Officer
Tae-Wook has been Chief Technology Officer since 2017 overseeing in-house research and development. Prior to his current appointment, he served as a Director of NGS Service Division at Macrogen, Inc. He was responsible for the entire laboratory activities of Macrogen's NGS and biochip services aimed for genome research. He holds a doctorate and master’s degree in microbiology from Seoul National University
Head of Pharmaceutical Development
Prior to joining Kobiolabs as Head of Pharmaceutical Development, he was a director of business development at Alvogen Korea where he led portfolio management, new product launch and various domestic and overseas partnering. He has 20 years of pharmaceutical industry experience in R&D and BD field with various companies from R&D driven big Korean conglomerates (LG Life Science & CJ Cheiljedang) to multinational company (Alvogen). He earned a M.S. in Medicinal Chemistry from Seoul National University.
Securing ₩4billion won investment
(CJ Cheiljedang&Timewise investment)
Selected as a Research and Business Development (R&BD) project by the Ministry of Trade, Industry, and Energy
Received the Ministry of Science and ICT Award
Selected as a Military Service Business by the Ministry of National Defense
Registered as a participant in MIT-lTP
Innovative Technology Development Project of the Small
and Medium Business Administration
Securing ₩10 billion won investment
(Atinum Investment, Company K, and Stonebridge)
Selected as a core technology development business by the Ministry of Trade, Industry, and Energy
Innovative Technology Development Project of the Small and Medium Business Administration
Selected as a global technology innovation IP strategic development business by the Korea Intellectual Property Strategy Agency
Partnership MOU between Kobiolabs and CKD Bio
Selected as an investment-linked business growth R&D support project by the Ministry of Science, ICT, and Future Planning
Selected as an immunity mechanism control technology by the Ministry of Science, ICT, and Future Planning
Investment promotion (CKD start-up investment)
Selected as an IP R&D strategic development business by Korea Intellectual Property Strategy Agency
Selected for the high value-added food technology development project by the Ministry of Agriculture, Food, and Rural Affairs
Secured the investment of Seoul Techno Holdings Inc.
Selected as an investment-linked mentoring business by the Small and Medium Business Administration
Certified by the Ministry of Environment as a Virus Inspection Agency
Selected as a venture business start-up support business by the Small and Medium Business Administration
Technology transfer MOU with Seoul National University Industry–Academy Cooperation Foundation
Selected as a Research Exchange and International Industry Development Support Business by the Ministry of Science, ICT, and Future Planning
Established a Kobiolabs affiliated research institute
(Center for Microbiome Therapeutics; approved by the Korea Industrial Technology Association)
Selected as the Research Achievement Commercialization Support Project by the Ministry of Science, ICT, and Future Planning
Certified by Kibo Technology Fund as a venture business
Founded Kobiolabs, Inc.
Providing opportunities for happy life and realizing dreams, developing products for customers to enjoy happy healthy lives, and striving to provide high investment return for our investors.
Passion Persistence Partnership
- Our company guarantees diversity and autonomy
- Our company will strive to create an atmosphere where employees can exercise their creative thinking and passio
- To Provide a comfortable and fulfilling atmos-phere for our employees to develop their skills
- To develop useful products for the healty living of our clients
- To offer our best efforts and high returns for our investors
The leaf in the logo symbolizes life and nature. The circle around the leaf represents the microbiome with beneficial interactions in the human body and the environment